BioGX

BioGX Inc. is a global molecular diagnostics company focused on supporting the health and safety of communities worldwide. The company develops and manufactures PCR assays, reagents, and instruments for clinical and other laboratory testing, serving customers in the United States and internationally. Its assay portfolio covers a broad range of testing needs, including respiratory and bloodborne infections, antimicrobial resistance, gastrointestinal and urinary pathogens, sexual and women’s health, meningitis, tropical diseases, and food, water, and pharmaceutical quality control.

BioGX offers CE-IVD-marked products, FDA Emergency Use Authorized COVID-19 tests, and Xfree™ direct PCR assays designed to work without an extraction step. Its Sample-Ready™ reagents combine assay components in a single lyophilized tube, helping laboratories expand testing menus and use compatible PCR platforms. The company also provides custom-designed reagents and Open Source Reagents manufacturing services for laboratories developing or outsourcing production of their own tests. BioGX’s product range includes the pixl real-time PCR platform and a PCR result analyzer, alongside technical resources, product documentation, webinars, and customer support.